Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Non-Pegylated Liposomal Doxorubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Non-Pegylated Liposomal Doxorubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Norethisterone (Onc Adjacent) |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Norethisterone (Onc Adjacent)
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Olanzapine (Onc Adjunct) |
Corticosteroid / Antipsychotic / Antidopaminergic | Both (Solid & Hematologic) | ||
|
Molecule
Olanzapine (Onc Adjunct)
Therapeutic Category
Supportive Care (Antiemetic/Adjunct)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Corticosteroid / Antipsychotic / Antidopaminergic |
||||
Omacetaxine Mepesuccinate |
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic | Both (Solid & Hematologic) | ||
|
Molecule
Omacetaxine Mepesuccinate
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
||||
Omega-3 Fatty Acid Supplements (Onc Nutrition) |
Appetite Stimulant / Anabolic Agent | Both (Solid & Hematologic) | ||
|
Molecule
Omega-3 Fatty Acid Supplements (Onc Nutrition)
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
||||
Ondansetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Ondansetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
Oral Azacitidine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Oral Azacitidine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Ortataxel |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Ortataxel
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Orteronel |
CYP17 / Androgen Synthesis Inhibitor | Solid Tumour (Prostate) | ||
|
Molecule
Orteronel
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
||||
Ospemifene (Onc Adjacent) |
Selective Estrogen Receptor Modulator (SERM) | Solid Tumour (Breast) | ||
|
Molecule
Ospemifene (Onc Adjacent)
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Modulator (SERM) |
||||
Oxaliplatin |
Platinum Compound | Solid Tumour | ||
|
Molecule
Oxaliplatin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
||||
Oxycodone |
Opioid / Adjuvant Analgesic | Both (Solid & Hematologic) | ||
|
Molecule
Oxycodone
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
||||
Non-Pegylated Liposomal DoxorubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
Norethisterone (Onc Adjacent)Hormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
Olanzapine (Onc Adjunct)Supportive Care (Antiemetic/Adjunct) |
|
|
Therapeutic Category
Supportive Care (Antiemetic/Adjunct)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Corticosteroid / Antipsychotic / Antidopaminergic |
|
Omacetaxine MepesuccinateCytotoxic Chemotherapy / Miscellaneous |
|
|
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
|
Omega-3 Fatty Acid Supplements (Onc Nutrition)Supportive Care (Nutrition/Cachexia) |
|
|
Therapeutic Category
Supportive Care (Nutrition/Cachexia)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Appetite Stimulant / Anabolic Agent |
|
OndansetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|
Oral AzacitidineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
OrtataxelCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
OrteronelHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
|
Ospemifene (Onc Adjacent)Hormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Modulator (SERM) |
|
OxaliplatinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
|
OxycodoneSupportive Care (Analgesic) |
|
|
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
|